Case Presentation:
Our patient is the fourth child of non‐consanguineous parents, born to a 23‐year‐old mother at a 41 weeks gestational age via normal delivery. Birth weight was 1520 grams with a length of 39cm (both below 3rd percentile). He was monitored in the NICU for IUGR and was found to have a blood sugar of 400 mg/dl in the first week of life. Lab results revealed: C peptide <0.5, insulin level <0.5, Cystic Fibrosis DNA negative, Pancreatic elastase 1 < 100. Chromosomal analysis showed normal male karyotype. Physical examination was negative for dysmorphic features, however, an ejection systolic murmur was present. An ECHO revealed ASD, peri‐membranous VSD, bicuspid aortic valve, and mild branch proximal RPA stenosis. An abdominal ultrasound, MRI and CT failed to show any pancreatic tissue. The patient was managed with insulin and pancreatic enzymes. In the first year of life, his growth velocity was 2.375 cm/month and weight gain was 415grams/month. At the age of 13 months, due to interim increase in severity of pulmonary stenosis, he had balloon valvuloplasty. During his second year of life, his growth velocity decreased to 0.73cm/month and weight gain was 100grams/month, and in his third year it was 0.7cm/month and weight gain was 185grams/month. Consequently, at 43 months, IGF 1 and growth hormone levels were found to be 14 and 0.7 respectively which were below normal, and the patient was started on growth hormone replacement. In his fourth year of his life, he gained 0.62 cm per month and weight increased by 218 grams per month, and in the fifth year, his growth velocity was 1.5cm/month and weight gain was 440grams/month. Gene testing including unipaternal disomy of chromosome 6, oligonucleotide‐based chromosomal microarray and IPF1 gene mutations were negative. However, GATA6 mutation was found to be present.
Discussion:
Neonatal diabetes is a rare form of diabetes with an estimated prevalence of 1:400,000 neonates. Pancreatic agenesis with permanent neonatal diabetes mellitus is a rare condition with high neonatal mortality. Mutations in 20 genes are known to cause diabetes presenting in the first year of life, some of which are also associated with additional pathologies including congenital heart disease, biliary malformation and cerebellar agenesis.
Conclusions:
Thus, delineation of the genetic underpinnings of this rare disease can affect the prognosis, management and genetic counseling of the relatives. We believe that all babies with this rare condition should have a genetic workup. Further understanding of this disease will aid in management and future prognosis of this rare condition.